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Appropriate development of regulatory T (Treg) cells
is necessary to prevent autoimmunity. Neonatal
mice, unlike adults, lack factors required for Treg
cell development. It is unclear what these missing
factors are. However, signals emanating from the
T cell receptor (TCR), the costimulatory receptor
CD28, and the family of gc-dependent cytokine
receptors are required for Treg cell development.
Herein we demonstrate that expression of a constitu-
tively active Stat5b transgene (Stat5b-CA) allowed
for Treg cell development in neonatal mice and re-
stored Treg cell numbers inCd28/mice. Sequence
analysis of TCR genes in Stat5b-CA Treg cells indi-
cated that ectopic STAT5 activation resulted in
a TCR repertoire that more closely resembled that
of naive T cells. UsingMHCII tetramers to identify an-
tigen-specific T cells, we showed that STAT5 signals
diverted thymocytes normally destined to become
naive T cells into the Treg cell lineage. Our data sup-
port a two-step model of Treg cell differentiation
in which TCR and CD28 signals induce cytokine
responsiveness and STAT5-inducing cytokines then
complete the program of Treg cell differentiation.
INTRODUCTION
Autoimmune disease is a consequence of the generation of self-
reactive T cells. Althoughmost self-reactive T cells are deleted in
the thymus via negative selection, some self-reactive T cells
escape this process. Therefore, a second mechanism involving
the generation of CD4+ regulatory T (Treg) cells in the thymus
has evolved to prevent autoimmunity (Shevach, 2000). Although
several distinct types of T cells capable of exerting suppressive
activity have now been described, the best characterized are
CD4+ T cells that express the transcription factor Foxp3 (referred
to hereafter as Foxp3+ Treg cells). Signals required for Foxp3+112 Immunity 28, 112–121, January 2008 ª2008 Elsevier Inc.Treg cell differentiation have been shown to include high-affinity
interactions between the T cell receptor (TCR) and major histo-
compatability class II (MHC II):peptide complexes (Aschenbren-
ner et al., 2007; Bensinger et al., 2001). In addition, work from
three different groups has demonstrated that the TCR repertoire
of Foxp3+ Tregs overlaps extensively with that of self-reactive
T cells; in contrast, only limited overlap was seen with naive
peripheral T cells (Hsieh et al., 2006; Pacholczyk et al., 2006;
Wong et al., 2007). Other signals required for Foxp3+ Treg cell
development include CD28:B7 costimulatory signals (Tai et al.,
2005; Tang et al., 2003). This has been attributed, in part, to
a role for CD28 in generating IL2 required for Foxp3+ Treg cell
homeostasis. However, CD28 appears to play an additional,
as-yet-undefined role in Foxp3+ Treg cell development (Tai
et al., 2005). Taken together, these studies have led to the con-
clusion that effective Foxp3+ Treg cell differentiation requires
both CD28:B7 costimulatory signals and relatively high-affinity
TCR interactions with MHCII:peptide complexes.
In contrast to the clearly accepted importance of TCR- and
CD28-dependent signals for Foxp3+ Treg cell differentiation,
the role of IL-2 in this process has been quite controversial.
Early studies using IL-2Rb transgenic mice supported a role for
IL-2Rb-dependent signals in Foxp3+ Treg cell development in
the thymus (Malek et al., 2000; Malek et al., 2002). In contrast,
other studies demonstrate that young Il2/ and Il2ra/ mice
have relatively normal numbers of thymic and peripheral
Foxp3+ T cells (D’Cruz and Klein, 2005; Fontenot et al., 2005b).
These latter findings seemed to convincingly rule out a require-
ment for IL-2 in Foxp3+ Treg cell differentiation. However, unlike
Foxp3+ Treg development in Il2/ or Il2ra/ mice, we have re-
cently found that Foxp3+ Treg cell development in Il2rb/ and
Il2/ 3 Il15/ mice is dramatically impaired (Burchill et al.,
2007). Similar findings were reported by Soper et al. (2007).
Thus, IL-2Rb-dependent signals play a key role in effective
Foxp3+ Treg cell development.
Several pieces of evidence indicate that IL-2 (and IL-15)
entrain Foxp3+ Treg cell differentiation via activation of STAT5.
For example, transgenic mice expressing a constitutively active
form of STAT5 (called Stat5b-CA) have a marked increase in the
percentage and total number of Foxp3+ Treg cells in both the
thymus and spleen (Burchill et al., 2003). Furthermore, crossing
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restores Foxp3+ Treg cell development in the thymus. Likewise,
IL-2Rb mutants that have been engineered to signal exclusively
through STAT5 also restore Foxp3+ Treg cells (Burchill et al.,
2007). Conversely,mice lackingSTAT5 in developing thymocytes
fail to generate Foxp3+ Treg cells (Burchill et al., 2007; Yao et al.,
2007). Thus, althoughmultiple cytokines can induce Foxp3+ Treg
cell differentiation, they all do so via STAT5 activation.
Although we now have some appreciation of the signals re-
quired to induce Foxp3+ Treg cell differentiation, the process still
remains enigmatic. Work from the Rudensky and Chatila labs
has demonstrated that mice lacking functional Foxp3 exhibit
precursors that can induce transcription of a green fluorescent
protein (GFP) cDNA knocked into the Foxp3 gene locus. These
cells exhibit many other hallmarks of Foxp3+ Treg cells, including
increased CD25 expression, but do not exhibit suppressor activ-
ity or prevent autoimmune disease in vivo (Gavin et al., 2007; Lin
et al., 2007). Likewise, neonatal mice that lack Foxp3+ Treg cells
do express a population of CD4+CD25+Foxp3 thymocytes
(Fontenot et al., 2005a). It was unclear at that time what these
cells were, although it was speculated that they might be
Foxp3+ Treg cell progenitors that failed to complete differentia-
tion because of the absence of as-yet-uncharacterized factors.
Thus, a key question that remains is whether high-affinity TCR
and CD28 signals induce an autonomous program that leads
to Foxp3+ Treg cell differentiation or whether this process occurs
viamultiple steps and requires the influence of other factors such
as cytokines. Herein, we present data supporting a two-step
model of Foxp3+ Treg cell lineage commitment. The first step
requires high-affinity TCR and CD28 signals that lead to the gen-
eration of thymocytes with enhanced cytokine responsiveness;
a second step, involving cytokine- and STAT5-dependent sig-
nals, completes the process of Foxp3+ Treg cell differentiation.
Moreover, this linkage of TCR-CD28-dependent and cytokine-
STAT5-dependent signals is important in shaping the TCR reper-
toire of Foxp3+ regulatory T cells.
RESULTS
STAT5 Activation in Neonatal Thymocytes
Induces Regulatory T Cell Development
To test potential cooperation between TCR and IL-2R signaling
pathways in promoting Foxp3+ Treg cell development, we uti-
lized a transgenic mouse model in which a mutant form of the
transcription factor STAT5 (referred to herein as Stat5b-CA) is
expressed throughout lymphocyte development (Burchill et al.,
2003). Although the Stat5b-CA construct we used is typically re-
ferred to as constitutively active, it still requires phosphorylation
on Tyr-699 for activation (Onishi et al., 1998). In the absence of
exogenous cytokines, the Stat5b-CA transgene results in low
levels of constitutive STAT5 activity ex vivo. Phosphorylation
of STAT5b-CA is further increased after exposure to STAT5-
activating cytokines; thus, the transgene is best described as
a weakly constitutively active, but hyperactivateable form of
STAT5b (Will et al., 2006). Using these mice, we examined
whether STAT5-dependent signals could induce Foxp3+ Treg
cell development in 1-day-old neonatal mice. Previous studies
have demonstrated that such mice are essentially devoid of
CD4+Foxp3+ Tregs (Fontenot et al., 2005a). We reasoned there-fore that if STAT5 signals are sufficient to drive Foxp3+ Treg de-
velopment, then we should see Foxp3+ Tregs in neonatal mice,
which normally lack such cells. Consistent with previous find-
ings, we observed that newly generated CD4+HSAhiFoxp3+
Tregs are virtually absent in the thymus of littermate control
(LMC) mice; in contrast, we observed a substantial population
of CD4+HSAhiFoxp3+ thymocytes in 1-day-old Stat5b-CA mice
(Figure 1). Thus, STAT5b-CA expression promotes the develop-
ment of Foxp3+ Treg cells under conditions that are normally not
permissive for the differentiation of such cells.
Constitutive Activation of STAT5 Rescues Regulatory
T Cell Development in Il2rg/ and Cd28/ Mice
Although STAT5b-CA expression clearly induces Foxp3+ Treg
cell differentiation in neonatal mice, it is unclear what upstream
factors it is compensating for. Previous studies have demon-
strated that neonatal dendritic cells expressmuch lower amounts
of the costimulatory ligands B7-1 and B7-2; furthermore, these
cells arequitepoor at inducing immune responses (Muthukkumar
et al., 2000). Thus, one possibility is that neonatal mice lack suffi-
cient expression of B7-1 and B7-2 on thymic antigen-presenting
cells to induce Foxp3+ Treg cell differentiation. An alternative
possibility is thatneonatalmicemay lackgc-dependentcytokines
that are required for Foxp3+ Treg cell differentiation. To test these
two possibilities, we introduced the Stat5b-CA transgene onto
Cd28/ and Il2rg/ backgrounds to examinewhether constitu-
tive STAT5 signals can drive Foxp3+ Treg cell development in the
absence of costimulatory-dependent or gc-cytokine-dependent
signals. The Stat5b-CA transgene restored Foxp3+ Treg cell
numbers in the absence of gc, indicating that STAT5 activation
can restore Foxp3+ Treg cell development in the absence of all
gc-dependent cytokines (Figure 2A). Importantly, the Foxp3+
Figure 1. STAT5b-CA Expression Drives Early Foxp3+ Treg Cell
Development
Thymii were harvested from neonatal mice, enumerated, and stained with the
cell-surface antibodies CD4, CD8, CD25, HSA, and intracellular Foxp3 for
analysis by flow cytometry. Similar results were found with Foxp3-GFP re-
porter mice. Data are representative of three independent experiments with
seven to ten mice per group.Immunity 28, 112–121, January 2008 ª2008 Elsevier Inc. 113
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cells. Specifically, in Il2rg/mice, which lack Foxp3+ Tregs, the
small number of T cells that remain show an activated phenotype
as determined by upregulated CD69 and downregulated CD62L
expression. This phenomena is reversed in Stat5b-CA3 Il2rg/
mice (Figure S1 available online). Moreover, T cell numbers are
restored in Stat5b-CA 3 Il2rg/ mice, and the mice remain
healthy up to at least 9 months of age, suggesting that they
have a functional Foxp3+ Treg cell population. Further, we found
that thymic Foxp3+ Treg cell numbers were also restored in
Stat5b-CA 3 Cd28/mice (Figures 2B and 2C). Foxp3+ thymo-
cytes from Stat5b-CA 3 Cd28/ mice retained high expression
of additional markers indicative of a Foxp3+ Treg cell phenotype,
such asCD25 andGITR, suggesting that we had restored a normal
population of Foxp3+ regulatory T cells (Figure 2D). A potential ca-
veattotheaboverescueexperiments isthat it isdifficult todetermine
whether these findings result from induced Foxp3+ Treg cell differ-
entiation or just enhanced proliferation and/or survival of the few
Treg cells that emerge in Cd28/ mice. Nevertheless, these data
provide evidence that CD28 signals may be upstream of STAT5
activation and suggest the possibility that CD28 signals induce
cytokine responsiveness during Foxp3+ Treg cell differentiation.
Ectopic STAT5 Activation Diverts Thymocytes
into the Regulatory T Cell Lineage
We next wanted to determine whether STAT5 activation could
restore Foxp3+ Treg cell development in the absence of high-
Figure 2. Constitutive Activation of STAT5 Drives
Foxp3+ Treg Cell Development in the Absence of
gc Stimulation and CD28 Stimulation
(A and B) Thymii were harvested from 4–6-week-old
C57Bl/6 (littermate control, LMC), Stat5b-CA 3 Il2rg/,
and Il2rg/ mice (A) or Stat5b-CA 3 Cd28/ and
Cd28/ mice (B) and stained with antibodies to the cell-
surface markers CD4, CD8, and intracellular Foxp3. Num-
bers indicate the percentage of CD4+CD8 thymocytes
inside the gate.
(C) Numbers of CD4+CD8Foxp3+ cells from LMC (white
slashed bars), Cd28/ (black bars), and Stat5b-CA 3
Cd28/ (white bars) mice were calculated from total lym-
phocyte numbers and flow-cytometry analysis in (A). Error
bars represent standard error of the mean (SEM). Data are
representative of three independent experiments using
a total of six to eight mice per group.
(D) Shown is CD25 (left panel) or GITR (right panel) expres-
sion on CD4+Foxp3+ thymocytes from LMC (gray shaded
histogram), Cd28/ (blue line), or Stat5b-CA 3 Cd28/
mice (red line). Data are representative of three indepen-
dent experiments.
affinity TCR signals. Mice lacking MHC class II
are defective in positive selection of all CD4+ thy-
mic T cells. Thus, crossing ofStat5b-CAmicewith
MHC class II-deficient mice is likely to be unin-
formative. In addition, we wished to be able to
unambiguously differentiate between STAT5 ef-
fects on postselection Foxp3+ Treg cell expan-
sion versus preselection induction of Foxp3+
Treg cell development. To circumvent these
issues, we examined whether the repertoire of TCRs expressed
in the Foxp3+ Treg cell pool was perturbed in Stat5b-CA mice.
Specifically, recent studies have demonstrated that both thymic
and peripheral Foxp3+ T cell populations have diverse TCR rep-
ertoires that exhibit very limited overlap with the TCR repertoire
of CD4+Foxp3 naive T cells (Hsieh et al., 2004, 2006; Pacholc-
zyk et al., 2006). To test whether constitutive activation of STAT5
alters the TCR repertoire of Foxp3+ Treg cells, we utilized a strat-
egy (Moon et al., 2007) employing tetramers of the MHC class II
molecule I-Ab covalently bound to the 2W1S variant of peptide
52-68 of the MHC class II molecule I-Ea (Crawford et al., 1998;
Rees et al., 1999) (referred to hereafter as the 2W1S-tetramer).
We used this 2W1S-tetramer in conjunction with magnetic
bead enrichment to isolate all 2W1S-specific T cells in the spleen
and lymph nodes of a single mouse (Figure S2). Enriched cells
were subsequently stained with a panel of additional markers
to characterize the 2W1S-tetramer-specific population (Fig-
ure S3). Staining was specific because the 2W1S-tetramer-
positive population is not observed in mice restricted to a single
TCR specificity such as TEa TCR Tg 3 Rag1/ (Grubin et al.,
1997) or SM1 TCR Tg 3 Rag1/ mice (McSorley et al., 2002)
(Figure S3). As expected, virtually all 2W1S-tetramer-specific
CD4+ T cells are naive (CD44lo) in mice that have not been pre-
viously exposed to the 2W1S peptide (Figure S3). Importantly,
we found that CD4+2W1S+ T cells from B6 mice are almost
entirely CD25 and Foxp3 (Figure 3A), demonstrating that this
TCR specificity is strikingly underrepresented in the Treg pool.114 Immunity 28, 112–121, January 2008 ª2008 Elsevier Inc.
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ment of 2W1S-Specific Foxp3+ Treg Cells
(A) Spleens and lymph nodes were isolated and pooled
from LMC or Stat5b-CA mice. After magnetic-bead en-
richment, cells were stained with the surface molecules
CD3, CD4, CD8, and CD25 to isolate relevant T cell popu-
lations and with the lineage-specific antibodies CD11b,
CD11c, NK1.1, GR-1, and B220 to gate out non-T cells.
CD3+CD4+ cells were then analyzed for 2W1S and CD25
(top panels) or intracellular Foxp3 expression (bottom
panels). Numbers in the quadrant represent percentage
of cells.
(B) Bar graphs represent the percent Foxp3+ cells among
the 2W1S (black bars) and 2W1S+ (white bars) popula-
tions. Error bars represent SEM; p values were calculated
with the two-tailed Student’s t test. Data are representa-
tive of five independent experiments utilizing a total of
six LMC and seven Stat5b-CA mice.In contrast, approximately 46% ± 9.2% of 2W1S-tetramer-spe-
cific T cells fromStat5b-CAmice are Foxp3+ (Figures 3A and 3B).
Furthermore, the percentage of 2W1S-specific Foxp3+ T cells is
not significantly different (p = 0.24) than the average distribution
of all other TCR specificities in the Foxp3+ Treg cell lineage
(64.2% ± 5.9%) (Figure 3B). These results demonstrate that con-
stitutive activation of STAT5 diverts 2W1S-tetramer-specific
cells that would normally develop into naive CD4+ T cells into
the Foxp3+ Treg cell lineage. Thus, the presence of the Stat5b-
CA transgene alters the TCR selection bias that typically charac-
terizes Foxp3+ Treg cell differentiation.
A Stat5b-CA Transgene Alters the T Cell Receptor
Repertoire of Regulatory T Cells
Although the above findings show that expression of the Stat5b-
CA transgene resulted in selection of a large fraction of 2W1S-
tetramer-specific T cells into the Foxp3+ Treg cell lineage, the
conclusions drawn from these experiments are limited because
of the fact that only one TCR specificity was assayed. Therefore,
we examined the ability of the Stat5b-CA transgene to divert
T cell progenitors into the Foxp3+ Treg cell lineage by analyzing
the TCR sequence diversity in Foxp3+ and Foxp3 populations
from Stat5b-CA and LMC mice. To address this issue, we
made use of mice expressing both a TCRb transgene and
a Foxp3-GFP reporter (Hsieh et al., 2006); the TCRb transgene
fixes TCRb chain diversity whereas the Foxp3-GFP reporter
allows us to specifically isolate Foxp3+ Treg cells. Previous stud-
ies have documented that Foxp3+ Treg cells in the thymus and
spleen show considerable overlap in TCR gene usage; in con-
trast, there is little overlap in TCR gene usage between naive
T cells and Foxp3+ Treg cells in either the spleen or thymus
(Hsieh et al., 2004). To examine the effect of ectopic STAT5
activation on the Foxp3+ Treg cell TCR repertoire, we sequenced
over 1000 productively rearranged TCR Va2 genes from Stat5b-
CA and LMC CD4+Foxp3+ and CD4+Foxp3 thymocytes. Con-
sistent with previous reports, we found that TCR Va2 gene usage
in CD4+Foxp3+ thymocytes from LMCmice is different from that
observed in CD4+Foxp3 naive T cells. Specifically, we found
that only 5% of unique TCR Va2 sequences in the CD4+Foxp3
thymocytes from LMC mice or Stat5b-CA mice were also pres-
ent in the CD4+Foxp3+ Tregs from LMC mice (Figure 4A, blackbars). In contrast, a much greater percentage of the unique
TCR Va2 rearrangements in LMC and Stat5b-CA non-Tregs
were found in CD4+Foxp3+ thymocytes from Stat5b-CA mice
(15% and 20%, respectively) (Figure 4A, gray bars). We also
examined skewing of the Foxp3+ Treg cell TCR repertoire by
comparing the relative frequency at which specific TCR Va2 se-
quences could be found in a larger database of TCR sequences
obtained from splenic Foxp3+ Treg cells, Foxp3CD44lo naive
T cells, and Foxp3CD44hi memory or effector T cells (Hsieh
et al., 2006). To analyze these results we plotted individual
TCR sequences obtained from CD4+Foxp3+ thymocytes on the
x axis and the relative frequency at which this particular
sequence could be found in wild-type splenic CD4+Foxp3+
T cells (green), CD4+Foxp3CD44lo naive T cells (blue), and
CD4+Foxp3CD44hi memory or effector T cells (pink) on the
y axis (Figure 4B). This analysis demonstrated an increase in
the number of TCR Va2 sequences that were found in Stat5b-
CA versus LMC CD4+Foxp3+ thymocytes, which were also
observed in splenic CD4+Foxp3 naive T cells (Figure 4B). To
quantitate the magnitude of this difference more precisely, we
took the area represented by the green, blue, and pink frequency
distributions in Figure 4B and plotted them as a bar graph (Fig-
ure 4C). From this graph it is clear that the presence of the
Stat5b-CA transgene greatly expands the number of TCR se-
quences in the Foxp3+ Treg cell repertoire that are more typically
found in the naive T cell repertoire (Figure 4C, compare blue bars
for Foxp3+ Treg cells in LMC versus Stat5b-CA mice). These
findings demonstrate that expression of a constitutively active
form of STAT5 alters the TCR selection bias that is normally as-
sociated with Foxp3+ Treg cell development and subsequently
expands the repertoire of sequences found in Tregs to include
many more non-Treg-specific TCR sequences.
STAT5 Activation Converts CD25Foxp3 Thymocytes
into CD25+Foxp3+ Regulatory T Cells
To further test the ability of STAT5 activation to drive Foxp3+
Treg cell differentiation, we made use of a recent observation
by Lio and Hsieh, who identified CD4+CD25+Foxp3 thymocytes
as penultimate progenitors of Foxp3+ Treg cells that can be
rapidly differentiated into Foxp3+ Treg cells by IL-2 plus IL-7 ad-
dition (Lio and Hsieh, 2008). In contrast, the CD4+CD25Foxp3Immunity 28, 112–121, January 2008 ª2008 Elsevier Inc. 115
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ing that they are not Foxp3+ Treg cell progenitors. We predicted
that if STAT5 activation downstream of TCR-dependent selec-
tion events is a key second step in Foxp3+ Treg cell differentia-
tion, then we should be able to convert CD4+CD25Foxp3
non-Treg progenitors into Foxp3+ Treg cells in Stat5b-CA but
not LMC mice. To examine this issue, we used Foxp3-GFP
reporter mice (Fontenot et al., 2005c) to identify Foxp3+ and
Foxp3 thymocyte subsets. We then sorted CD4+Foxp3-
GFPCD25 thymocytes from Stat5b-CA and LMC mice and
placed them in culture overnight in media alone, IL-7, or IL-7
and IL-2. Consistent with reports from Lio and Hsieh, we found
that CD4+Foxp3-GFPCD25 thymocytes neither spontane-
ously converted into Foxp3+ Tregs nor could be converted into
Foxp3+ Tregs by cytokine treatment. In contrast, CD4+Foxp3-
GFPCD25 thymocytes from Stat5b-CA mice could be con-
verted into Tregs after addition of either IL-7 or IL-7 and IL-2 (Fig-
ures 5A and 5B); stimulation of these cells with IL-2 alone also
worked (Figure S4) but was substantially less effective because
CD4+Foxp3-GFPCD25 thymocytes not only fail to express the
IL-2Ra chain but express very low amounts of the IL-2Rb chain
as well (data not shown), making these cells very poorly respon-
sive to IL-2. In contrast, the synergistic affect of IL-7 and IL-2
appears to be due to the ability of IL-7 to modestly upregulate
CD25 in CD4+Foxp3-GFP thymocytes from Stat5b-CA mice,
thereby rendering them more responsive to IL-2.
Figure 4. Constitutive STAT5 Activation Al-
ters the TCR Repertoire of Thymic Foxp3+
Treg Cells
(A) Shown is the percentage of unique (left panel)
or total (right panel) TCR Va2 sequence overlap
of LMC CD4+Foxp3 (LMC GFP-) or Stat5b-CA
CD4+Foxp3 (Stat5b-CA GFP) with CD4+Foxp3+
Treg cells from either LMC (black bars) or Stat5b-
CA (gray bars) mice.
(B) Shown is the relative frequency with which
a particular TCR Va2 sequence from either LMC
or Stat5b-CA thymocytes are found in either
CD4+CD44loFoxp3 (blue), CD4+CD44hiFoxp3
(pink), and CD4+Foxp3+ (green) peripheral splenic
T cells.
(C) To quantitate the magnitude of the differences
shown above, we took the area represented by the
CD4+CD44loFoxp3 (blue), CD4+CD44hiFoxp3
(pink), and CD4+Foxp3+ (green) frequency distri-
butions in Figure 4B and plotted them as a bar
graph.
The observation that the Stat5b-CA
transgene only converts CD4+Foxp3-
GFPCD25 thymocytes into Treg cells
in vitro after addition of cytokines sug-
gests that a relatively high threshold of
STAT5 signaling is required for this pro-
cess. To test this hypothesis, we mea-
sured expression of phospho-STAT5
in both wild-type (WT) and Stat5b-CA
CD4+Foxp3-GFPCD25 thymocytes in
the Treg conversion assay. As shown in
Figure 5C, unstimulated LMC CD4+Foxp3 thymocytes
exhibited a low level of phospho-STAT5 expression that was in-
creased after exposure to cytokines. Unstimulated CD4+Foxp3
thymocytes from Stat5b-CA mice exhibited higher basal phos-
pho-STAT5 staining; this is consistent with the constitutively
activated nature of the Stat5b-CA transgene. After stimulation
of CD4+Foxp3 T cells from Stat5b-CA mice with IL-2 and
IL-7, we observed two distinct patterns of phospho-STAT5 ex-
pression (Figure 5C). Cells that remained negative for Foxp3-
GFP did not exhibit an increase in phospho-STAT5 relative to
unstimulated cells. In contrast, cells that induced Foxp3-GFP ex-
pression demonstrated a marked increase in phospho-STAT5
staining. These findings indicate that a threshold of STAT5 acti-
vation is required for CD4+Foxp3 thymocytes to convert into
CD4+Foxp3+ Treg cells. Taken together, our findings strongly
support a model in which high-affinity TCR-CD28 signals induce
the ability to respond to gc-dependent cytokines; subsequent
encounter with such cytokines results in the final conversion of
Foxp3 Treg progenitors in the thymus into Foxp3+ Treg cells.
STAT5-Dependent Regulatory T Cell Development
Require Histone Deacetylase Activity but Not TGFb
The conversion of CD4+CD25+Foxp3-GFP thymocytes into
CD4+Foxp3-GFP+ Treg cells resembles, at least superficially,
the conversion of mature splenic T cells into Treg cells after
anti-CD3, TGFb, and IL2 stimulation that has beenwell described116 Immunity 28, 112–121, January 2008 ª2008 Elsevier Inc.
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2002). Therefore, we examined whether TGFb produced by con-
verted Tregs, or potentially present in bovine calf serum, might
be required for this process.Neutralizing TGFbhadonly amodest
effect on the conversion of CD4+CD25Foxp3-GFP progenitor
cells derived from Stat5b-CAmice (Figure 6A). Conversely, addi-
tion of exogenous TGFb resulted in minimal enhancement of the
conversion process (ranging from no effect up to a 10% in-
crease; data not shown). Moreover, using CD4+CD25+Foxp3-
GFP Treg progenitor cells obtained from wild-type mice, Lio
and Hsieh found that neither adding exogenous TGFb nor neu-
tralizing TGFb antibodies affected the conversion process (Lio
and Hsieh, 2008). Thus, the cytokine-dependent conversion of
the thymic Treg progenitors that we have identified differs sub-
stantially from the conversion of splenic CD4+ T cells because
it does not require TGFb. This is consistent with other published
data on the requirements for thymic development of natural Treg
cells, which have been shown to be TGFb independent (Marie
et al., 2005).
STAT5 associates with both histone acetyltransferases (HATs)
and histone deacetylases (HDACs) and these interactions have
been suggested to play an important role in regulating STAT5-
dependent responses (Nakajima et al., 2001; Pfitzner et al.,
1998). Therefore, we examined whether blocking histone deace-
tylase activity would augment or inhibit the cytokine-dependent
Treg cell conversion process. For these studies, we inhibited
Figure 5. Constitutive STAT5 Activation
Drives CD4+Foxp3CD25 Thymocytes into
the Foxp3+ Treg Cell Lineage In Vivo
(A) Shown is a representative example of Foxp3
expression among purified CD4+Foxp3CD25
thymocytes from either LMC (top) or Stat5b-CA
(bottom) mice after 24 hr in vitro stimulation with
media alone, IL-7 (5 ng/ml) or IL-7 plus IL-2
(10 U/ml).
(B) Bar graph represents the percent of cultured
cells from either LMC (white bar) or Stat5b-CA
(black bar) mice that induced expression of
Foxp3 after in vitro culture. Graph shows mean ±
SEMs, n = 3. Data are representative of two inde-
pendent experiments.
(C) CD4+Foxp3-GFPCD25 thymocytes from
LMC and Stat5b-CA mice were placed in culture
overnight with or without IL-2 and IL-7. Cells
were subsequently stained for phospho-STAT5
expression and analyzed by flow cytometry.
Shown are relative phospho-STAT5 expression
for unstimulated CD4+Foxp3-GFP LMC cells
(blue), unstimulated Stat5b-CA CD4+Foxp3-
GFP cells (green), stimulated LMC CD4+Foxp3-
GFP cells (orange), and stimulated Stat5b-CA
CD4+Foxp3-GFP cells (yellow) and CD4+Foxp3-
GFP+ cells (red). A representative example of two
experiments is shown.
HDACs with either the pan-HDAC inhibi-
tor trichostatin A (TSA) or amore selective
inhibitor, apicidin, which preferentially
targets HDAC2 and HDAC3 (Khan et al.,
2008). TSA functioned as expected by in-
creasing global histone H3 and H4 acetylation in CD4+ thymo-
cytes (Figure S5). However, when added into the conversion as-
say, both TSA and apicidin completely blocked the ability of
CD4+CD25Foxp3-GFP progenitors from Stat5b-CA mice to
convert into CD4+CD25+Foxp3-GFP+ Treg cells (Figure 6B).
Thus, these results suggest that STAT5-dependent recruitment
of HDACs, most likely HDAC2 or HDAC3, is required for tran-
scription of the Foxp3 gene.
DISCUSSION
Two of the fundamental questions remaining in the field of
Foxp3+ Treg cell development are what governs this develop-
mental process and how is it that the Foxp3+ Treg cell TCR
repertoire is matched to that of self-reactive T cells? Herein we
provide data demonstrating that linked TCR-CD28- and
STAT5-dependent signals play a key role in both of these pro-
cesses. Moreover, our findings definitively address the ongoing
controversy regarding the role of the IL-2R andSTAT5 signaling in
Foxp3+ Treg cell development. Previous studies using Il2rb/,
Il2rg/, and Stat5a/Statb/ mice have suggested a role for
these molecules in Foxp3+ Treg cell differentiation (Burchill
et al., 2007; Fontenot et al., 2005b; Malek et al., 2000; Yao
et al., 2007). However, in those studies it was difficult to distin-
guish between a role for these factors in postselection expansion
of Foxp3+ Treg cell numbers and a role in preselection inductionImmunity 28, 112–121, January 2008 ª2008 Elsevier Inc. 117
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that STAT5 signals can divert non-Treg progenitors into the
Foxp3+ Treg cell lineage clearly demonstrate that STAT5 signals
play an important role in the preselection differentiation of
Foxp3+ Tregs. Taken together, our data support a two-step
model of Foxp3+ Treg cell differentiation in which TCR and
CD28 signals first enhance the ability of cells undergoing nega-
tive selection to respond to IL-2R-STAT5 signals; subsequent
encounter with STAT5-inducing ligands completes the differen-
tiation process that drives Foxp3+ Treg cell development.
The above model is supported by substantial other data. First,
STAT5 binds to the Foxp3 promoter in Foxp3+ Treg cells,
suggesting that STAT5 may induce Foxp3 expression (Burchill
et al., 2007; Yao et al., 2007). Second, thymocytes undergoing
negative selection upregulate expression of the IL-2Ra and
IL-2Rb chains (Bassiri and Carding, 2001). IL-2Ra upregulation
occurs only in CD4-destined thymocytes because it is upregu-
lated during negative selection in transgenic mice expressing
a MHC class II but not a MHC class I restricted TCR (Baldwin
and Hogquist, 2007). This may explain why CD4+ thymocytes
can differentiate into Treg cells but CD8+ thymocytes typically do
not. Third, IL-2 is found selectively in the medulla of the thymus
(Yang-Snyder and Rothenberg, 1998), a region that correlates
with Treg cell development (Aschenbrenner et al., 2007; Fonte-
Figure 6. Histone Deacteylase Activity but Not TGFb Signaling Is
Required for Cytokine-STAT5-Dependent Conversion of CD4+
Thymocytes into Foxp3+ Treg Cells
(A) CD4+Foxp3-GFPCD25 cells from Stat5b-CA mice were stimulated for
24 hr in vitro with media alone (left panel), IL-2 (10 U/ml), IL-7 (5 ng/ml) and
10 mg/mL isotype control antibody (middle panel), or 10 mg/mL anti-TGFb
antibody (right panel).
(B) CD4+Foxp3-GFPCD25 thymocytes from Stat5b-CA mice were stimu-
lated overnight with IL-2 (10 U/mL) plus IL-7 (5 ng/mL) and 0.2% DMSO (left
panel), 100 nM trichostatin A (TSA, middle panel), or 800 nM apicidin (right
panel). Twenty-four hours later, cells were stained for CD4 expression and an-
alyzed for Foxp3-GFP expression by flow cytometry. Shown is a representative
example of three experiments.118 Immunity 28, 112–121, January 2008 ª2008 Elsevier Inc.not et al., 2005a). Finally, a CD4+CD25+Foxp3 Treg precursor
has been identified that can be converted to CD4+CD25+Foxp3+
Treg cells by addition of IL-2 or IL-15 in vitro (Lio and Hsieh,
2008). Taken together, these studies support a role for IL-2-
STAT5-dependent signals in driving Treg cell development.
A remaining question is why all CD4+ thymocytes in Stat5b-CA
mice are not converted into Foxp3+ Treg cells. One potential
explanation for this observation is provided by recent studies ex-
amining the methylation status of the Foxp3 gene. For example,
changes in DNA CpG methylation and histone H4K3-trimethyla-
tion have been found in developing CD4+Foxp3+ thymocytes
(Floess et al., 2007). Likewise, TCR-CREB-dependent signals in-
duce changes in the methylation status of histones associated
with the Foxp3 gene locus (Kim and Leonard, 2007). A second
potential explanation is that relatively strong TCR-CD28 signals
may be required to induce a state of heightened cytokine re-
sponsiveness. Only cells in which both the IL-2Ra and IL-2Rb
chain have been upregulated, as well as other positive regulators
of IL-2R signaling such as Socs2 (Tannahill et al., 2005), will
probably be capable of augmenting STAT5 signals to the thresh-
old level required to complete Treg cell differentiation in WT
mice. We suggest that in Stat5b-CA mice, the other factors
contributing to enhanced cytokine signaling play a lesser but still
important role. On the basis of these findings, we propose
a model in which high-affinity TCR signals both open the
Foxp3 gene locus and induce the potential for cytokine respon-
siveness; only cells that subsequently encounter a STAT5-induc-
ing cytokine will induce Foxp3 expression, thereby completing
the program of Foxp3+ Treg cell differentiation.
An important question is how STAT5 signals result in Treg
differentiation. STAT5 binds to several regions within the Foxp3
gene (Burchill et al., 2007; Yao et al., 2007) and is known to inter-
act with histone acetyltransferases and histone deacetylases.
A common perception is that HDACs inhibit gene transcription
by deacetylating histones and thereby reducing gene accessibil-
ity (Kuo and Allis, 1998). However, mounting evidence suggests
that HDACs can also deacetylate other factors (Nusinzon and
Horvath, 2005). Along these lines, inhibition of HDACs can pre-
vent the induction of STAT5-dependent gene transcription
(Rascle et al., 2003; Xu et al., 2003). Perhaps the best example
of this is transcription of the Id1 gene in pro-B cells (Xu et al.,
2003). Id1 expression is regulated by a pro-B-cell-specific
enhancer that contains critical binding sites for C/EBPb and
STAT5. In this system, STAT5 recruits HDAC1, which deactey-
lates C/EBPb. Deacetylation of C/EBPb results in enhanced
DNA binding and induction of Id1 gene transcription. Inhibiting
HDAC activity prevents STAT5 from cooperating with C/EBPb
to induce Id1 transcription; conversely, introduction of a mutant
form of C/EBPb that can no longer be acetylated removes the
requirement for STAT5 in the induction of Id1 transcription.
Although we cannot rule out all other interpretations, at this
point the simplest explanation for our findings is that STAT5
recruits a HDAC that acts on a second factor to induce Foxp3
transcription.
We believe our data also provide an explanation for several
other outstanding questions in the field. For example, work
from several labs has demonstrated that transgenic mice coex-
pressing both a single TCR and its respective ligand generate
a substantial percentage of Foxp3+ Tregs (Apostolou et al.,
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gand is required to induce Treg differentiation. In contrast, work
by van Santen et al. using mice in which the amount of agonist
ligand could be carefully titrated found that increasing amounts
of agonist ligand did not result in an increase in Foxp3+ Treg
cells. Rather, they found that Foxp3+ Treg cells were more resis-
tant than non-Treg cells to negative selection and that this
resulted in an increase in the percentage of Foxp3+ Treg cells,
but not an actual increase in their numbers (van Santen et al.,
2004). Their conclusion was that enhanced survival rather than
induced differentiation accounted for the results in the previous
studies. We suggest that our model may account for these latter
findings. Notably, in the studies by van Santen et al., the agonist
ligand was expressed in both the thymic cortex and medulla. On
the basis of our findings that IL-2Rb-induced STAT5 activation is
required to complete Foxp3+ Treg cell differentiation, we would
predict that increased agonist ligand in the cortex would result
primarily in negative selection due to the limited amounts of
IL-2 available there. In contrast, we predict that forced expres-
sion of IL-2 in the cortex would rescue these negatively selected
cells by converting them into Foxp3+ Tregs.
A related question concerns the dual role that TCR and CD28
signals play in both negative selection and Foxp3+ Treg cell de-
velopment. Work from many labs has established that TCR and
CD28 signals are required for both of these processes (Aschen-
brenner et al., 2007; Bensinger et al., 2001; Tai et al., 2005; Tang
et al., 2003). However, it is unclear how this common signaling
mechanism can lead to such dramatically different cell fates.
One possibility is that this simply reflects the overall strength of
signal, with the strongest TCR-CD28-dependent signals leading
to cell death whereas weaker TCR-CD28-dependent signals
promote Foxp3+ Treg cell differentiation. Although this is an
attractive explanation, formal proof for such a model is lacking.
We propose an alternativemodel in which high-affinity TCR stim-
ulation induces a program of negative selection that includes en-
hanced ability to respond to IL-2Rb-dependent ligands. Whether
these thymocytes die or emerge as Foxp3+ Tregs depends on
whether they subsequently encounter STAT5-inducing ligands
in the thymus. Intriguingly, this model would potentially allow
for enrichment of Tregs specific for Aire-induced self-antigens
that are localized in the medulla (Anderson et al., 2002; Aschen-
brenner et al., 2007) and thus have an increased probability
of encountering IL-2. In contrast, abundant self-antigens, which
would be predicted to induce negative selection at a high fre-
quency in the cortex, would preferentially promote negative-se-
lection-induced cell death due to the absence of IL-2. Such
a mechanism would result in greater numbers of Foxp3+ Tregs
directed to low-abundance self-antigens presented in the thymic
medulla, and thus the very cells that might be expected to
escape negative selection at higher frequency.
EXPERIMENTAL PROCEDURES
Mice
Stat5b-CA transgenic mice were previously described (Burchill et al., 2003).
C57BL/6 mice were purchased from the Jackson Laboratories (Bar Harbor,
ME). Foxp3-GFP3 TCR TCli Tg3 TCRa+/mice were provided by Dr. Alexan-
derRudensky (UniversityofWashington) (Hsiehet al., 2006).Miceused for anal-
ysis were 4–6 weeks old, unless otherwise noted. The University of Minnesota
Institutional Animal Care andUse Committee approved all animal experiments.2W1S Tetramer Assays
Thymii and peripheral lymphoid organs were isolated from Stat5b-CA and
C57BL/6mice between the ages of 4–6 weeks and analyzed for 2W1S-specific
T cell populations (Moon et al., 2007). Pooled spleen and lymph nodes were
incubated with phycoerythrin (PE)- or APC-labeled 2W1S:I-Ab tetramers
followed by incubation with anti-PE or anti-APC microbeads (Miltenyi Biotech,
Auburn, CA). Tetramer-specific T cells were then enriched with magnetic LS
columns (Miltenyi Biotech) and enumerated by flow-cytometric counting
beads (Caltag, Carlsbad, CA). Enriched T cell populations were stained with
CD3, CD4, CD8, CD11b, CD11c, B220, F4/80, GR1, and NK1.1 and intracel-
lular Foxp3 as previously described (Burchill et al., 2007).
TCR Sequencing
Foxp3+ and Foxp3populationswere isolated from Foxp3-GFP3 TCRb6 Tg3
TCRa+/ Stat5b-CA and C57BL/6 mice with a Facs Aria cell sorter. TCR Va2
sequences were cloned and analyzed as previously described (Hsieh et al.,
2006).
Treg Conversion Assays
Thymii from either Foxp3-GFP or Stat5b-CA 3 Foxp3-GFP male mice were
disrupted with ground-glass slides. Cells were subsequently stained with
cell-surface antibodies to CD8 for depletion of CD8+ and CD4+CD8+ T cells
with magnetic bead columns (Miltenyi Biotech). CD4+CD8Foxp3CD25+
and CD4+CD8Foxp3CD25+ thymocytes were further purified with a Facs
Aria cell sorter (Becton Dickinson). Isolated thymocyte subsets were resus-
pended in DMEM containing 10% FCS (Atlas Biologicals), 50 mM b-mercap-
toethanol (Sigma), 1% L-glutamine (Mediatech Cellgrow), 1 mM sodium pyru-
vate (Mediatech Cellgrow), 10 mM HEPES (Mediatech Cellgrow), and 1%
streptomycin/penicillin (Mediatech Cellgrow). Cells were either seeded into
96-well round-bottom plates in the presence of media alone, IL-7 (5 nM), or
IL-2 (10 U/ml) plus IL-7 (5 nM). Some cultures were treated with 10 mg/mL
anti-TGFb (R&D systems, St. Paul, MN), 10 mg/mL isotype control IgG1 anti-
body (GIR-208; kindly provided by Dr. Robert Schreiber, Washington Univer-
sity), 100 nM Trichostatin A (Sigma, St. Louis, MO), 800 nM Apicidin (Sigma,
St. Louis, MO), or DMSO (0.2%). IL-2 and IL-7 were obtained from the Biolog-
icals Resource Branch, National Cancer Institute Preclinical Repository. Cells
were incubated for 24 hr at 37C in a 5%CO2 incubator. Foxp3 expression was
analyzed with an LSR II (Becton Dickinson) and Flow Jo Software (Treestar).
Phopho-STAT5 Staining and Western Blotting
Sorted CD4+CD25Foxp3-GFP thymocytes were stimulated for 24 hr with
10 U/mL IL-2 and 5 ng/mL IL-7 (PeproTech). Cells were then harvested and
stained for phospho-STAT5 as previously described (Will et al., 2006). For
acetyl-H3 and -H4 western blots, CD4+ T cells were stimulated overnight
with IL-2 plus IL-7 and either TSA or DMSO. Nuclear lysates were run on
a 12% SDS-polyacrylamide gel, transferred to a nitrocellulose membrane,
and blocked for 1 hr with 5% nonfat dry milk in 13 PBS and 0.1% Tween. Blots
were incubated with primary anti-acetyl-H3 and -H4 antibodies (Upstate
Biology) and secondary goat anti-Rabbit IgG followed by visualization with
an Odyssey Infrared Imaging System.
Supplemental Data
Five figures are available at http://www.immunity.com/cgi/content/full/28/1/
112/DC1/.
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